Verloes–Gillerot–Fryns syndrome
Verloes–Gillerot–Fryns syndrome is a rare genetic disorder characterized by a spectrum of clinical features including craniofacial anomalies, neurological impairments, and gastrointestinal complications. This syndrome is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
Symptoms and Characteristics[edit | edit source]
The clinical presentation of Verloes–Gillerot–Fryns syndrome can vary significantly among affected individuals. Common symptoms include:
- Craniofacial Anomalies: Patients often exhibit distinct facial features such as a high forehead, wide nasal bridge, and cleft lip or palate.
- Neurological Impairments: Developmental delay, intellectual disability, and seizures are frequently observed in individuals with this syndrome.
- Gastrointestinal Complications: Issues such as diaphragmatic hernia, omphalocele, and other abdominal wall defects are common.
- Cardiac Anomalies: Congenital heart defects may also be present.
Genetics[edit | edit source]
Verloes–Gillerot–Fryns syndrome is caused by mutations in a gene that has not been conclusively identified. The inheritance pattern is autosomal recessive, which means that both parents must carry one copy of the mutated gene to pass the disorder onto their children.
Diagnosis[edit | edit source]
Diagnosis of Verloes–Gillerot–Fryns syndrome is based on clinical evaluation and the presence of characteristic features. Genetic testing may help confirm the diagnosis, although the specific gene associated with this syndrome has not been identified. Prenatal testing may be available for families with a known history of the syndrome.
Treatment[edit | edit source]
There is no cure for Verloes–Gillerot–Fryns syndrome. Treatment is symptomatic and supportive, focusing on managing the individual symptoms and complications. This may include surgical interventions for cleft lip or palate, management of gastrointestinal and cardiac anomalies, and therapies to support developmental and intellectual disabilities.
Prognosis[edit | edit source]
The prognosis for individuals with Verloes–Gillerot–Fryns syndrome varies depending on the severity of symptoms and the presence of life-threatening complications. Early intervention and supportive care can improve the quality of life for those affected by the syndrome.
Verloes–Gillerot–Fryns syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD